Literature DB >> 16131426

Review of guidelines for bone mineral density testing and treatment of osteoporosis.

E Michael Lewiecki1.   

Abstract

Clinical practice guidelines (CPGs) are systematically developed statements intended to influence the behavior of health care providers and improve patient care. There are many CPGs with recommendations for selection of patients for bone mineral density testing and pharmacologic treatment of osteoporosis. Health care provider adherence rates for these CPGs are low. The multiplicity of osteoporosis CPGs directed to the same health care providers may play a role in their limited utilization in clinical practice. Similarities, differences, and conflicts in osteoporosis CPGs with wide distribution in the United States were examined. The analysis showed similarities as well as substantial variation in the patient populations addressed, inconsistency of some recommendations, differences in clinical risk factors identified, and sometimes limitations in clinical applications. If the number and diversity of osteoporosis CPGs is adversely affecting their use in clinical practice, then collaboration of stakeholder organizations to develop more consistent CPGs, in combination with systems-based approaches for their implementation, may improve patient care and reduce the burden of osteoporotic fractures.

Entities:  

Mesh:

Year:  2005        PMID: 16131426     DOI: 10.1007/s11914-005-0014-x

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  43 in total

Review 1.  Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction.

Authors: 
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

2.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

3.  Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group.

Authors:  R S Hayward; M C Wilson; S R Tunis; E B Bass; G Guyatt
Journal:  JAMA       Date:  1995-08-16       Impact factor: 56.272

4.  Intervention thresholds for osteoporosis in the UK.

Authors:  John A Kanis; Frederik Borgstrom; Niklas Zethraeus; Olof Johnell; Anders Oden; Bengt Jönsson
Journal:  Bone       Date:  2004-12-15       Impact factor: 4.398

5.  Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; N Kreiger; W J McIsaac; G A Darlington; J V Tu
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

6.  Missed opportunities for prevention of osteoporotic fracture.

Authors:  Teresa C Gallagher; Olga Geling; Florence Comite
Journal:  Arch Intern Med       Date:  2002-02-25

7.  Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density.

Authors:  E Lydick; K Cook; J Turpin; M Melton; R Stine; C Byrnes
Journal:  Am J Manag Care       Date:  1998-01       Impact factor: 2.229

8.  Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2002 Mar-Apr       Impact factor: 2.953

9.  Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.

Authors:  Susan E Andrade; Sumit R Majumdar; K Arnold Chan; Diana S M Buist; Alan S Go; Michael Goodman; David H Smith; Richard Platt; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2003-09-22

10.  Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap.

Authors:  Seifeddin El-Jack; Andrew Kerr
Journal:  N Z Med J       Date:  2003-11-07
View more
  13 in total

Review 1.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

2.  Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP.

Authors:  E Michael Lewiecki
Journal:  Nat Clin Pract Rheumatol       Date:  2009-03

3.  Diminished bone strength is observed in adult women and men who sustained a mild trauma distal forearm fracture during childhood.

Authors:  Joshua N Farr; Sundeep Khosla; Sara J Achenbach; Elizabeth J Atkinson; Salman Kirmani; Louise K McCready; L Joseph Melton; Shreyasee Amin
Journal:  J Bone Miner Res       Date:  2014-10       Impact factor: 6.741

4.  Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations.

Authors:  R Hamood; H Hamood; I Merhasin; L Keinan-Boker
Journal:  Osteoporos Int       Date:  2018-11-09       Impact factor: 4.507

Review 5.  Selecting patients for osteoporosis therapy.

Authors:  Stuart L Silverman
Journal:  Curr Osteoporos Rep       Date:  2006-09       Impact factor: 5.096

6.  Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

Authors:  B Dawson-Hughes; A N A Tosteson; L J Melton; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

Review 7.  Intravenous zoledronic acid for the treatment of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2008-03       Impact factor: 5.096

8.  Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors.

Authors:  Leslie Spangler; Onchee Yu; Elizabeth Loggers; Denise M Boudreau
Journal:  J Womens Health (Larchmt)       Date:  2013-01-30       Impact factor: 2.681

9.  Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).

Authors:  Barbara Ruaro; Andrea Casabella; Sabrina Paolino; Carmen Pizzorni; Massimo Ghio; Chiara Seriolo; Luigi Molfetta; Patrizio Odetti; Vanessa Smith; Maurizio Cutolo
Journal:  Clin Rheumatol       Date:  2018-10-06       Impact factor: 2.980

10.  Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice.

Authors:  Laurie J Pencille; Megan E Campbell; Holly K Van Houten; Nilay D Shah; Rebecca J Mullan; Brian A Swiglo; Maggie Breslin; Rebecca L Kesman; Sidna M Tulledge-Scheitel; Thomas M Jaeger; Ruth E Johnson; Gregory A Bartel; Robert A Wermers; L Joseph Melton; Victor M Montori
Journal:  Trials       Date:  2009-12-10       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.